The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing cancer immunotherapies.

Total Raised

$123 M

Rounds

2

Links

Verticals

Biotechnology
Health Care
Life Science
Therapeutics

Investment History

  1. Series B

    Feb 2024

    $43M

  2. Series B

    Jan 2023

    $80M

Team

Ivan Cheung

CEO

Gordon Freeman

Scientific Co-Founder

Xingxing Zang

Scientific Co-Founder

Leena Gandhi

Chief Medical Officer